Why the study?
Is pre-β1-lipoprotein closely related to Lp(a) lipoprotein and associated with coronary heart disease?
Is pre-β1-lipoprotein closely related to Lp(a) lipoprotein and associated with coronary heart disease?
Pre-β1-lipoprotein is closely related or identical to Lp(a) lipoprotein, suggesting its potential utility as a biomarker for identifying individuals at high risk for developing coronary heart disease.
Answers are grounded in this paper and cite their sources.
May support Lp(a) measurement for CHD risk assessment; leaves open prospective validation before clinical adoption.
Certain properties of the atypical serum lipoprotein, referred to as pre‐ β 1 ‐lipoprotein, suggested that it might be identical to the lipoprotein carrying the Lp(a) antigen: Lp(a) lipoprotein. Both lipoprotein phenomena are under genetic control and occur in a certain proportion of healthy people. Pre‐ β 1 ‐lipoprotein occurs more frequently in patients with coronary heart disease (CHD) than in the healthy population. The present study of Finnish CHD patients was undertaken to investigate whether a close relationship could be revealed between pre‐ β 1 ‐lipoprotein and Lp(a) lipoprotein, as well as between Lp(a) lipoprotein and CHD. Both expectations were realised, and we conclude that pre‐ β 1 ‐lipoprotein is very closely related, if not identical to Lp(a) lipoprotein. If the present results are confirmed in future studies, serum analysis for Lp(a) lipoprotein/pre‐ β 1 ‐lipoprotein may become a useful tool for the identification in early life of members of a subpopulation which is particularly at risk for developing CHD.
No takes yet. Share an insight, caveat, or question.
Berg et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: